7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-02-14 2010-02-14 2010-02-14 2009-02-14 2009-02-14 2008-02-14 2008-02-14 2007-02-14 2007-02-14 2006-02-14 2006-02-14 2005-02-14 2005-02-14 2004-09-30 2004-06-30 2004-02-14 
      
    		                                                                         
      revenues:
    		                                                                         
      commercial product sales
    		22,305,000 22,454,000 18,973,000                                                                       
      collaborations and services
    		26,506,000 22,845,000 29,376,000                                                                       
      royalties
    		33,319,000 31,228,000 30,005,000           304,000                                                            
      total revenues
    		82,130,000 76,527,000 78,354,000 76,776,000 70,079,000 72,386,000 66,263,000 58,472,000 51,253,000 48,611,000 40,626,000 36,059,000 32,825,000 18,894,000 11,992,000 12,515,000 22,211,000 23,280,000 17,436,000 18,443,000 15,352,000 15,114,000 16,235,000 15,993,000 14,595,000 15,002,000 17,448,000 16,032,000 4,469,000 3,893,000 3,465,000 4,530,000 2,043,000 2,163,000 3,009,000                                       
      expenses:
    		                                                                         
      cost of goods sold – commercial
    		4,498,000 4,607,000 3,768,000                                                                       
      cost of revenue – collaborations and services
    		15,705,000 15,961,000 13,748,000 14,796,000 14,826,000 14,772,000 14,779,000 11,953,000 10,259,000 9,013,000 10,683,000                                                               
      research and development
    		14,063,000 13,675,000 11,022,000 11,138,000 12,926,000 11,816,000 10,013,000 9,236,000 9,989,000 6,453,000 5,605,000 7,156,000 4,136,000 4,893,000 3,536,000 3,886,000 3,655,000 2,329,000 2,442,000 1,545,000 1,484,000 1,464,000 1,755,000 2,021,000 1,580,000 1,632,000 1,667,000 1,084,000 2,043,000 2,967,000 2,644,000 3,507,000 4,361,000 3,123,000 3,129,000 1,560,000 3,917,000 4,310,000 5,130,000 6,219,000 6,341,000 7,737,000 9,377,000 17,560,000 19,178,000 37,323,000 26,182,000 1,496,561,000 27,281,000 27,052,000 26,398,000 1,391,326,000 25,453,000 26,638,000 24,156,000 1,286,334,000 23,132,000 1,292,381,000 1,241,875,000 1,241,875,000 1,040,371,000 1,040,371,000 873,059,000 873,059,000 680,289,000 680,289,000 379,671,000 379,671,000 245,205,000 245,205,000 11,695,000   
      selling, general and administrative
    		29,088,000 31,622,000 25,014,000         17,344,500 22,638,000 26,043,000 20,697,000 22,727,000 17,221,000 20,056,000 17,413,000 17,121,000 13,899,000 13,670,000 14,350,000 15,721,000 16,666,000 16,609,000 25,673,000 17,976,000 19,394,000 21,731,000 20,618,000 23,278,000 17,725,000 18,566,000 15,389,000 15,333,000 13,135,000 11,110,000                                    
      (gain) loss on foreign currency transaction
    		-120,000     -529,000 -1,399,000                                                                   
      total expenses
    		63,234,000 71,228,000 56,061,000 50,281,000 57,319,000 55,776,000 49,541,000 50,614,000 46,156,000 46,890,000 46,624,000 48,849,000 42,435,000 39,348,000 33,248,000 36,483,000 28,801,000 33,553,000 23,627,000 42,190,000 24,482,000 23,029,000 23,356,000 27,345,000 23,374,000 25,954,000 30,962,000 23,762,000 26,012,000 24,430,000 30,254,000 33,367,000 30,222,000 33,734,000 22,611,000 24,237,000 44,125,000                                     
      income from operations
    		18,896,000 5,299,000 22,293,000 26,495,000 12,760,000 16,610,000 16,722,000 7,858,000 5,097,000 1,721,000 -5,998,000 -12,790,000 -9,610,000 -20,454,000 -21,256,000 -23,968,000 -6,590,000 -10,273,000 -6,191,000 -23,747,000 -9,130,000 -7,915,000 -7,121,000 -11,352,000 -8,779,000 -10,952,000 -13,514,000 -7,730,000 -21,543,000 -20,537,000 -26,789,000 -28,837,000 -28,179,000 -31,571,000 -19,602,000 -11,833,000 118,229,000 -19,124,000 -20,013,000 -272,863,000 -26,003,000 -24,051,000 -21,738,000 -30,103,000 -38,266,000 -69,846,000 -41,411,000 -2,107,882,000 -44,762,000 -41,585,000 -36,437,000 -1,947,791,000 -35,487,000 -44,054,000 -33,933,000 -1,804,345,000 -32,773,000 -1,811,767,000 -1,741,673,000 -1,741,673,000 -1,469,296,000 -1,469,296,000 -1,260,654,000 -1,260,654,000 -1,026,658,000 -1,026,658,000 -665,436,000 -665,436,000 -496,763,000 -496,763,000 -20,503,000 -18,382,000  
      yoy
    		48.09% -68.10% 33.32% 237.17% 150.34% 865.14% -378.79% -161.44% -153.04% -108.41% -71.78% -46.64% 45.83% 99.10% 243.34% 0.93% -27.82% 29.79% -13.06% 109.19% 4.00% -27.73% -47.31% 46.86% -59.25% -46.67% -49.55% -73.19% -23.55% -34.95% 36.66% 143.70% -123.83% 65.09% -2.05% -95.66% -554.67% -20.49% -7.94% 806.43% -32.05% -65.57% -47.51% -98.57% -14.51% 67.96% 13.65% 8.22% 26.14% -5.60% 7.38% 7.95% 8.28% -97.57% -98.05% 3.60% -97.77% 23.31% 38.16% 38.16% 43.11% 43.11% 89.45% 89.45% 106.67% 106.67% 3520.04% 3520.04%      
      qoq
    		256.60% -76.23% -15.86% 107.64% -23.18% -0.67% 112.80% 54.17% 196.17% -128.69% -53.10% 33.09% -53.02% -3.77% -11.32% 263.70% -35.85% 65.93% -73.93% 160.10% 15.35% 11.15% -37.27% 29.31% -19.84% -18.96% 74.83% -64.12% 4.90% -23.34% -7.10% 2.34% -10.74% 61.06% 65.66% -110.01% -718.22% -4.44% -92.67% 949.35% 8.12% 10.64% -27.79% -21.33% -45.21% 68.67% -98.04% 4609.09% 7.64% 14.13% -98.13% 5388.75% -19.45% 29.83% -98.12% 5405.58% -98.19% 4.02% 18.54% 18.54% 16.55% 16.55% 22.79% 22.79% 54.28% 54.28% 33.95% 33.95% 2322.88% 2322.88% 11.54%   
      operating margin %
    		                                   -95.40% 72.82%                                     
      other income:
    		                                                          38.16% 38.16% 43.11% 43.11% 89.45% 89.45% 106.67% 106.67% 3145.55% 3145.55%      
      interest income
    		2,628,000 1,832,000 1,956,000 2,825,000 3,179,000 3,177,000 3,434,000 1,725,000 1,580,000 1,547,000 1,302,000 957,000 663,000 516,000 377,000 48,000 36,000 25,000 3,000 2,000 18,000 14,000 133,000 203,000 220,000 255,000 318,000 196,000 144,000 55,000 106,000 115,000 65,000 58,000 55,000 15,000 28,000 26,000 15,000 10,000 2,000 3,000 3,000 5,000 1,000 1,000 1,000 37,000,000 2,000 1,000 1,000 36,994,000  1,000 1,000 36,971,000  36,986,000 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 275,000 123,000  
      interest expense
    		-1,364,000 -285,000 -4,645,000 -1,562,000 -1,801,000 -6,051,000 -2,567,000 -2,677,000 -2,815,000 -6,873,000                                                                
      interest expense on liability for sale of future royalties
    		-3,514,000 -3,473,000 -3,577,000 -3,452,000 -4,089,000 -4,383,000 -4,248,000                                                                   
      interest expense on financing liability
    		-2,456,000 -2,433,000 -2,410,000 -2,467,000 -2,470,000 -2,444,000 -2,447,000 -2,493,000 -2,459,000 -2,449,000 -2,424,000 -2,478,000 -2,466,000 -2,443,000 -2,371,000                                            36,953,000 36,953,000 36,892,000 36,892,000 35,875,000 35,875,000 26,736,000 26,736,000 11,629,000 11,629,000 6,448,000 6,448,000    
      impairment of available-for-sale investment
    		-6,409,000                                                                         
      other income
    		    32,000   -164,000 318,000 -143,000 111,000 105,000 -207,000   1,000 1,000 35,000 -276,000 -1,000 14,000 14,000 -4,000 -842,000 -52,000 -17,000 -14,000 -508,000 10,000 30,000 31,000    14,000 16,000 -27,000 -5,959,000 67,000 -104,000 67,000 -10,000 1,413,000 41,000 7,898,000 -370,000 -5,890,000 -2,950,000 10,000 15,000 23,000 -14,345,000 -2,651,000 13,347,000 1,382,000 -2,552,000 79,000 -1,267,000             40,000 14,000  
      gain on bargain purchase
    		    5,259,000                                                                     
      loss on settlement of debt
    		                                                                         
      total other income
    		-11,115,000 -4,359,000 -8,676,000 -18,050,000 110,000 -18,301,000 -5,828,000 -4,896,000 -3,376,000 -6,986,000 -3,797,000 -5,157,000 -4,822,000 -8,569,000 -4,742,000 -4,093,000 2,164,000 -25,250,000 -6,725,000 -2,664,000 -2,343,000 -2,337,000 -2,201,000 -2,911,000 -1,591,000 -1,435,000 -1,369,000 -2,021,000 -2,625,000  -3,596,000 -3,896,000 -4,707,000 -3,768,000 3,278,000                        -1,990,000 -1,990,000 -1,872,000 -1,872,000 -1,881,000 -1,881,000 -1,526,000 -1,526,000 -1,783,000 -1,783,000 -1,949,000 -1,949,000    
      income before income tax (benefit) expense
    		7,781,000                                                                         
      income tax (benefit) expense
    		-204,000                                                                         
      net income
    		7,985,000 668,000 13,158,000 7,422,000 11,550,000 -2,014,000 10,630,000 1,401,000 1,721,000 -5,265,000 -9,795,000 -17,947,000 -14,432,000 -29,023,000 -25,998,000 -28,061,000 -4,426,000 -35,523,000 -12,916,000 -26,411,000 -11,255,000 -10,252,000 -9,322,000 -14,263,000 -10,370,000 -12,387,000 -14,883,000 -9,751,000 -24,168,000 -22,675,000 -30,385,000 -32,784,000 -32,886,000 -35,339,000 -16,324,000 53,974,000 126,520,000 -29,959,000 -24,873,000 -277,019,000 -31,857,000 -28,910,000 -30,658,000 -36,441,000 -36,520,000 -73,365,000 -52,056,000 -2,158,495,000 -50,818,000 -46,124,000 -40,965,000 -1,987,327,000 -42,834,000 -36,578,000 -38,173,000 -1,811,139,000 -38,402,000 -1,816,267,000             -20,188,000 -18,245,000  
      yoy
    		-30.87% -133.17% 23.78% 429.76% 571.12% -61.75% -208.52% -107.81% -111.92% -81.86% -62.32% -36.04% 226.07% -18.30% 101.29% 6.25% -60.68% 246.50% 38.55% 85.17% 8.53% -17.24% -37.36% 46.27% -57.09% -45.37% -51.02% -70.26% -26.51% -35.84% 86.14% -160.74% -125.99% 17.96% -34.37% -119.48% -497.15% 3.63% -18.87% 660.18% -12.77% -60.59% -41.11% -98.31% -28.14% 59.06% 27.07% 8.61% 18.64% 26.10% 7.31% 9.73% 11.54% -97.99% -97.80% 4.30% -97.34% 25.82% 40.91% 40.91% 43.48% 43.48% 87.96% 87.96% 104.36% 104.36% 3493.37% 3493.37%      
      qoq
    		1095.36% -94.92% 77.28% -35.74% -673.49% -118.95% 658.74% -18.59% -132.69% -46.25% -45.42% 24.36% -50.27% 11.64% -7.35% 534.00% -87.54% 175.03% -51.10% 134.66% 9.78% 9.98% -34.64% 37.54% -16.28% -16.77% 52.63% -59.65% 6.58% -25.37% -7.32% -0.31% -6.94% 116.48% -130.24% -57.34% -522.31% 20.45% -91.02% 769.57% 10.19% -5.70% -15.87% -0.22% -50.22% 40.93% -97.59% 4147.50% 10.18% 12.59% -97.94% 4539.60% 17.10% -4.18% -97.89% 4616.26% -97.89% 4.60% 20.29% 20.29% 17.14% 17.14% 22.49% 22.49% 53.45% 53.45% 33.18% 33.18% 2338.48% 2338.48% 10.65%   
      net income margin %
    		                                   435.13% 77.93%                                     
      net income per share
    		0.03 0 0.04 0.03 0.04 -0.01 0.04 0.01 0.01 -0.02 -0.04 -0.07 -0.06 -0.11 -0.1 -0.11 -0.02 -0.14 -0.05 -0.12 -0.05 -0.05 -0.04 -0.07 -0.05 -0.07 -0.08 -0.04 -0.16 -0.16 -0.25 -0.29 -0.31 -0.35 -0.17 1.21 0.26 -0.07 -0.06 -0.68 -0.08 -0.07 -0.08 -0.09 -0.09 -0.19 -0.14 -0.12 -0.17 -0.16 -0.15 -0.178 -0.22 -0.23 -0.27 -0.255 -0.31                 
      weighted-average shares used for eps calculation
    		306,806 304,954 303,481 274,415 274,998 273,056 270,356 267,014 268,732 265,626                                                                
      gain on foreign currency transaction
    		 5,363,000 2,509,000 131,500 2,454,000   2,776,000 -2,065,000 251,000 954,000                                                -1,736,436,000 -1,736,436,000 -1,443,490,000 -1,443,490,000 -1,232,286,000 -1,232,286,000 -1,006,026,000 -1,006,026,000 -655,611,000 -655,611,000 -492,280,000 -492,280,000    
      loss on available-for-sale securities
    		                                                          40.91% 40.91% 43.48% 43.48% 87.96% 87.96% 104.36% 104.36% 3147.53% 3147.53%      
      income before income tax expense
    		 940,000 13,617,000 8,445,000 12,870,000 -1,691,000 10,894,000 2,962,000 1,721,000 -5,265,000 -9,795,000                                                0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%    
      income tax expense
    		 272,000 459,000 1,023,000 1,320,000 323,000 264,000                     -60,000  -240,000                                            
      net revenue – commercial product sales
    		   14,818,000 19,728,000 20,780,000 18,764,000 20,195,000 17,927,000 18,345,000 17,562,000                                                               
      revenue – collaborations and services
    		   18,532,500 23,268,000 26,014,000 24,848,000 17,249,000 13,108,000 11,211,000 11,386,000                                                               
      royalties – collaboration
    		   18,831,500 27,083,000 25,592,000                                                                    
      cost of goods sold
    		   4,808,000 3,197,000 5,605,000 3,819,000 6,114,000 3,995,000 5,224,000 5,530,000 4,081,000 5,021,000 4,617,000 2,284,000 4,295,000 3,812,000 4,411,000 4,315,000 3,652,000 3,591,000 3,677,000 4,164,000 4,632,000 7,099,000 4,327,000 4,020,000 4,996,000 5,303,000 5,095,000 4,008,000 5,018,000 4,575,000 5,086,000 2,548,000 1,554,000 4,331,000                                     
      selling
    		   9,047,250 13,093,000 11,495,000 11,601,000 11,024,000 13,440,000 14,002,000 13,310,000                                                               
      general and administrative
    		   8,542,000 10,823,000 12,617,000 10,728,000 9,511,000 10,538,000 11,947,000 10,542,000                            7,351,000 8,311,000 11,547,000 10,623,000 10,479,000 12,543,000 19,088,000 32,523,000 15,229,000 443,333,000 17,481,000 14,533,000 10,039,000 388,442,000 10,069,000 17,416,000 9,777,000 349,938,000 9,641,000 351,363,000             8,808,000   
      loss on extinguishment of debt
    		   -1,762,500  -7,050,000            -22,130,000          -191,250 -712,000  -825,000 -207,500  -830,000       -1,049,000                                 
      gain on available-for-sale securities
    		   -387,500  -1,550,000  233,000  932,000                                                                
      royalties – collaborations
    		      22,651,000 21,028,000 20,218,000 19,055,000 11,678,000                                                               
      benefit from income taxes
    		                                                                         
      interest expense on notes
    		          -2,786,000 -2,809,000 -2,812,000 -6,642,000 -2,748,000 -4,261,000 -2,709,000 -2,812,000 -5,422,000 -1,104,000 -1,057,000 -1,084,000 -1,071,000 -1,021,000 -4,126,000 -564,000 -593,000 -620,000 -993,000 -1,709,000 -1,794,000 -2,056,000 -2,310,000 -2,422,000 -2,706,000 -3,009,000 -4,166,000 -4,181,000 -4,221,000 -3,332,000 -4,145,000 -4,131,000 -9,622,000 -5,654,000 -5,424,000 -2,429,000 -4,042,000                           
      shares used to compute net income per share – basic and diluted
    		          263,969                                                331,725,000 331,725,000 260,759,000 260,759,000 219,429,000 219,429,000 178,183,000 178,183,000 117,569,000 117,569,000 83,262,000 83,262,000    
      net revenue — commercial product sales
    		           17,440,000 16,259,000 12,722,000 9,826,000 11,340,000 9,753,000 9,976,000 8,099,000 10,064,000 7,275,000 6,985,000 8,000,000                                                   
      revenue — collaborations and services
    		           9,544,000 10,346,000 5,868,000 2,166,000 1,175,000 12,458,000 13,304,000 9,337,000 8,379,000 8,077,000 8,129,000 8,235,000                                                   
      royalties — collaborations
    		           9,075,000 6,220,000                                                             
      cost of revenue — collaborations and services
    		           12,043,000 12,439,000 8,298,000 8,714,000 7,139,000 6,075,000 5,515,000 3,295,000 2,631,000 1,581,000 1,983,000 3,362,000                                                   
      asset impairment
    		               26,500 106,000   472,250  368,000                                                    
      gain on foreign currency translation
    		           -2,071,250 -1,799,000  -1,983,000   903,000 -3,838,000 4,008,000 3,927,000 1,867,000 -1,796,000 2,582,000 -3,807,000                                                 
      loss on purchase commitments
    		                 339,000                                                        
      gain on extinguishment of debt
    		               -4,300,000 4,930,000        3,529,000     772,000                                            
      income before benefit from income taxes
    		           -17,363,250 -14,432,000 -29,023,000 -25,998,000 -13,216,250 -4,426,000 -35,523,000 -12,916,000 -7,761,750 -11,473,000 -10,252,000 -9,322,000 -9,410,000 -10,370,000 -12,387,000 -14,883,000 -19,246,000 -24,168,000 -22,435,000 -30,385,000                     -29,498,250 -43,242,000 -36,578,000 -38,173,000 -1,811,113,000 -38,402,000 -1,816,241,000             -20,188,000 -18,245,000  
      shares used to compute net income per share - basic and diluted
    		           63,743.5 259,300 253,644 251,887 62,156 249,910                                                         
      (gain) loss on foreign currency translation
    		             -4,503,000  -1,564,000 -2,068,000         1,247,000 -1,935,000 -1,361,000 -728,000 -5,363,000    6,848,000                                        
      interest expense on mann group promissory notes
    		               -373,000 -94,000 -368,000 -1,030,000                                                       
      shares used to compute basic and diluted net income per share
    		                 249,295 246,631 54,639.75 229,668 213,880 212,467 47,946.5 199,906 188,054 187,434 34,576.75 153,597 140,054 120,911   99,864 95,744   455,305 428,858 4,431 405,199 401,018 398,916                               
      interest expense on promissory notes
    		                   -1,297,000 -1,318,000 -1,281,000 -1,259,000 -1,251,000 -1,162,000                                                 
      benefit for income taxes
    		                   54,500 218,000                                      -1,736,410,000 -1,736,410,000 -1,443,464,000 -1,443,464,000 -1,232,262,000 -1,232,262,000 -1,006,005,000 -1,006,005,000 -655,590,000 -655,590,000 -492,264,000 -492,264,000    
      impairment of commitment asset
    		                      1,521,000                                                   
      net revenue - commercial product sales
    		                       4,385,750 6,402,000 6,065,000 5,076,000 5,734,000 4,387,000 3,753,000 3,402,000 4,466,000 1,981,000  1,196,000 143,250 573,000                                     
      revenue - collaborations and services
    		                       7,375,500 8,193,000 8,937,000 12,372,000                                               
      revenue - other
    		                           13,250  53,000  1,000                                          
      cost of revenue - collaborations and services
    		                       1,378,000 1,836,000 2,139,000 1,537,000                                               
      interest expense on note payable to related party
    		                         -1,109,000 -1,080,000 -1,089,000 -1,074,000 -1,046,000 -1,114,000                 -1,280,750 -1,745,000 -1,689,000 -1,689,000 -30,504,000 -2,245,000 -3,028,000 -3,048,000 -20,485,000 -2,863,000 -19,927,000                
      net revenue - collaborations
    		                           58,000 82,000                                             
      property and equipment impairment
    		                                92,000 111,000                                        
      gain on purchase commitments
    		                                                                         
      change in fair value of warrant liability
    		                                -1,289,000 147,000 6,629,000 -2,510,000 13,185,000                                     
      net revenue - collaboration
    		                             87,000 63,000 63,000 62,000  63,000 40,445,250 161,781,000                                     
      total other
    		                             -1,898,000                             -14,678,000 -14,678,000 -2,116,000 -2,116,000            
      loss on foreign currency translation
    		                              2,984,000 3,019,250 3,684,000  1,545,000                                       
      product costs - collaboration
    		                                   5,685,500 22,742,000                                     
      gain on purchase commitment
    		                               -53,750 -215,000                                         
      interest expense on note payable to principal stockholder
    		                               -1,174,000 -1,173,000 -721,000 -714,000   -721,000 -721,000 -730,000 -729,000 -721,000 -714,000 -730,000 -729,000 -721,000 -714,000                           
      income before benefit for income taxes
    		                               -21,137,250 -32,886,000 -35,339,000 -16,324,000    -24,873,000 -277,019,000 -31,857,000 -28,910,000 -30,658,000 -36,441,000 -36,520,000 -73,365,000 -52,056,000 -2,158,877,000 -50,818,000 -46,124,000 -40,965,000                       
      income tax benefit
    		                                                   26,000 -408,000                     
      shares used to compute basic net income per share
    		                               4,109 104,703   -362,135 478,137                                     
      shares used to compute diluted net income per share
    		                               4,109 104,703   -362,281 482,744                                     
      net revenue—commercial product sales
    		                                 1,548,000                                        
      net revenue—collaboration
    		                                 63,000                             -1,511,000 -1,511,000 -1,511,000 -1,511,000        
      revenue—other
    		                                 552,000                                        
      revenue - bulk insulin sales
    		                                  1,750,000                                       
      revenue:
    		                                                                         
      total net revenue
    		                                   12,404,000 162,354,000                                     
      yoy
    		                                                                         
      qoq
    		                                   -92.36%                                      
      expense:
    		                                                                         
      interest expense on note payable to our principal stockholder
    		                                   -543,000 -729,000                                     
      income before income tax benefit
    		                                   17,922,500 126,520,000                                     
      revenue
    		                                                   3,131,000 35,000   3,081,000  3,131,000                
      operating expenses:
    		                                                                         
      product manufacturing
    		                                     3,704,000 7,532,000 51,754,000 8,115,000 5,691,000 1,882,000                               
      total operating expenses
    		                                     19,124,000 20,013,000 272,863,000 26,003,000 24,051,000 21,738,000 30,103,000 38,266,000 69,846,000 41,411,000 2,111,048,000 44,762,000 41,585,000 36,437,000 1,950,922,000 35,522,000 44,054,000 33,933,000 1,807,426,000 32,773,000 1,814,898,000             20,503,000 18,382,000  
      in-process research and development costs
    		                                                         19,726,000                
      goodwill impairment
    		                                                         151,428,000                
      deemed dividend related to beneficial conversion feature of convertible preferred stock
    		                                                         -22,260,000             -19,210,000   
      accretion on redeemable preferred stock
    		                                                         -952,000              4,000  
      net income applicable to common stockholders
    		                                           -40,485,250 -36,520,000 -73,365,000 -52,056,000 -2,181,707,000 -50,818,000 -46,124,000 -40,965,000 -2,010,539,000 -42,834,000 -36,578,000 -38,173,000 -1,834,351,000 -38,402,000 -1,839,479,000 3,081,000 3,081,000 2,988,000 2,988,000 2,988,000 2,988,000 2,968,000 2,968,000 2,958,000 2,958,000 2,858,000 2,858,000 -39,398,000 -18,241,000  
      shares used to compute basic and diluted net income per share applicable to common stockholders
    		                                           95,333 394,163 380,770 368,784 71,722.25 296,386 284,044 280,058 41,152.75 190,534 159,859 143,154 30,409 122,130                 
      interest expense on senior convertible notes and facility financing obligation
    		                                               -2,513,000 -4,323,000                         
      interest expense on senior convertible notes
    		                                                 -2,866,000 -2,863,000 -31,655,000 -2,859,000 -2,844,000 -2,575,000 -20,702,000 -2,845,000 -20,266,000 1,744,754,000 1,744,754,000 1,472,284,000 1,472,284,000 1,263,642,000 1,263,642,000 1,029,626,000 1,029,626,000 668,394,000 668,394,000 499,621,000 499,621,000    
      income taxes
    		                                                         -26,000 19,726,000 19,726,000   19,726,000 19,726,000 19,726,000 19,726,000 19,726,000 19,726,000 19,726,000 19,726,000    
      in—process research and development costs
    		                                                          151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000 151,428,000    
      income tax provision
    		                                                          -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000 -22,260,000    
      net income per share
    		0.03 0 0.04 0.03 0.04 -0.01 0.04 0.01 0.01 -0.02 -0.04 -0.07 -0.06 -0.11 -0.1 -0.11 -0.02 -0.14 -0.05 -0.12 -0.05 -0.05 -0.04 -0.07 -0.05 -0.07 -0.08 -0.04 -0.16 -0.16 -0.25 -0.29 -0.31 -0.35 -0.17 1.21 0.26 -0.07 -0.06 -0.68 -0.08 -0.07 -0.08 -0.09 -0.09 -0.19 -0.14 -0.12 -0.17 -0.16 -0.15 -0.178 -0.22 -0.23 -0.27 -0.255 -0.31  -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000 -952,000    
      basic and diluted
    		                                                          -1,759,648,000 -1,759,648,000 -1,466,702,000 -1,466,702,000 -1,255,498,000 -1,255,498,000 -1,029,238,000 -1,029,238,000 -678,823,000 -678,823,000 -515,492,000 -515,492,000 -1.4 -0.91  
      shares used to compute basic and diluted net income per share:
    		                                                                         
      basic and diluted
    		                                                                      28,051 19,975  
      research & development
    		                                                          -15,022,000 -15,022,000 -7,072,000 -7,072,000 -4,091,000 -4,091,000 -3,046,000 -3,046,000      14,311,000  
      general & administrative
    		                                                          -26,000 -26,000 -26,000 -26,000 -24,000 -24,000 -21,000 -21,000 -21,000 -21,000 -16,000 -16,000  4,071,000  
      basic and diluted – pro forma
    		                                                            19,726,000 19,726,000          -0.73  
      shares used to compute net income per share:
    		                                                                         
      basic and diluted
    		                                                                      28,051 19,975  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.